More than 300 oral and poster presentations from the nation’s experts in gynecological and obstetrical health will be shared at the Annual Clinical and Scientific Meeting of the American College of Obstetricians & Gynecologists (ACOG ACSM). The conference takes place in San Diego from May 6-8.
Today, the Food and Drug Administration (FDA) announced the approval of mavacamten, a new drug shown to provide relief to obstructive hypertrophic cardiomyopathy patients experiencing shortness of breath.
Cardiologists and cardiothoracic surgeons from the Smidt Heart Institute at Cedars-Sinai are available to discuss the latest advances in research, clinical care, transcatheter procedures and cardiothoracic surgery throughout the International Society for Heart and Lung Transplantation (ISHLT) Scientific Sessions 2022 and Heart Rhythm 2022.
Physician-scientists from the Smidt Heart Institute at Cedars-Sinai are working to identify genetic risk factors for cardiomyopathy—a collection of conditions that reduce the heart’s ability to pump blood to the rest of the body—and how inherited forms of the condition can be detected at earlier stages.
Throughout the month of April—Donate Life Month—experts from Cedars-Sinai Comprehensive Transplant Center and the Smidt Heart Institute are available for interviews on issues related to transplantation, immunology and organ donation.
Michelle Kittleson, MD, PhD, Director of Post-Graduate Education in Heart Failure and Transplantation and Director of Heart Failure Research in the Smidt Heart Institute, Can Discuss New Clinical Guidance
Cedars-Sinai’s newest department, Computational Biomedicine, is up and running, giving the Cedars-Sinai Newsroom an opportunity to speak with the department’s founding chair, Jason H. Moore, about the history of this relatively new field, how to mine big data and the future of artificial intelligence in healthcare.
Cedars-Sinai Cancer experts will present their latest advances in treatments and research at the American Association for Clinical Research (AACR) Annual Meeting 2022 in New Orleans, April 8-13. They will share their innovations to improve the quality of patient care.
Cedars-Sinai neurology experts are available to discuss the latest advances in research and clinical care for patients with disorders of the nervous system ahead of the 74th annual meeting of the American Academy of Neurology (AAN), happening April 2-7.
Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top-ranked cardiology and heart surgery programs, will present an array of innovative research data and lead discussions on medical breakthroughs during the American College of Cardiology (ACC) Annual Scientific Session & Expo, taking place in person and virtually April 2-4.
As mask mandates disappear across the U.S., many are eager to return to pre-pandemic life. But scientists warn against letting down our guard too soon, pointing out that new variants could arise in the months ahead.
There are no ifs, ands or “butts” about it: March is Colorectal Cancer Awareness Month and a timely reminder to get screened for one of the deadliest—and most preventable—cancers.
Cancer treatments save lives. They also might cause heart damage in the process. Cedars-Sinai research scientist Arun Sharma, PhD, wants to be able to predict when this might happen, and is creating models of the human heart by using stem cells derived from blood. The goal is to better personalize cancer treatments.
Cardiothoracic surgeons in the Smidt Heart Institute at Cedars-Sinai recently performed a groundbreaking robotic-assisted lung transplant.
Throughout the month of February—American Heart Month—the Cedars-Sinai Newsroom will highlight new research, heart-health recommendations and clinical and surgical advances. Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top heart and heart surgery programs, are available to address these timely heart-related topics.
Following Medicare’s decision today about paying for a new Alzheimer’s disease treatment only in limited circumstances, Zaldy Tan, MD, MPH, a highly respected memory and geriatric medicine specialist at Cedars-Sinai, is available to comment.
As the highly contagious omicron variant surges COVID-19 cases to record highs, some are wondering if they should intentionally get the virus in the hope of developing immunity.
First on the list: Get vaccinated and get a booster shot if you qualify.
Zahn, a professor of pediatrics and the director of the Guerin Family Congenital Heart Program in the Smidt Heart Institute, was the principal investigator for the multicenter clinical trial which led to the FDA's approval today. He says the new device will allow interventional cardiologists to treat more patients.
As the first cases of flu are reported in Los Angeles this season, public health experts are urging anyone who isn't already vaccinated to get the flu shot. It's the best protection against the flu, which could pummel the U.S. this winter after nearly disappearing last year.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
